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Objectives: To investigate the impact of the heart rate control on Cardiovascular
events and cardiac function in patients with ST-segment elevation myocardial
infarction (STEMI).
Methods: It was a retrospective analysis of 228 patients with ST-segment elevation
myocardial infarction treated in the department of Cardiology of the 1st Hospital of
Jilin University enrolled in this study from March, 2013 through March, 2014. The
patients were randomly divided into 2 groups of enhanced heart rate control group A
(112 cases) and control group B (116 cases).Group A: with Metoprolol Succinate
Sustained-release Tablets. Target resting heart rate was 55-65 beats / min. The starting
dose of Metoprolol Succinate Sustained-release Tablets was 47.5 mg, and we cali-
brated resting heart rate once a week, if the heart rate was greater than 65 beats / min,
the Metoprolol Succinate Sustained-release Tablets increase the amount of 23.75mg
until the resting heart rate reached the standard. Random sample of the same period of
hospitalization ST segment elevation myocardial infarction as a control group with no
Metoprolol Succinate Sustained-release Tablets. We recorded series of events within
one year including of episodes of angina, recurrent myocardial infarction, coronary
revascularization, heart failure, left ventricular end-diastolic diameter, serum brain
natriuretic peptide (BNP), left ventricular ejection fraction (LVEF), fatal arrhythmias
and cardiac deaths.
Results: Enhanced heart rate control group was signiﬁcantly lower in angina pectoris,
coronary revascularization, heart failure, cardiac death, re-infarction, fatal arrhyth-
mias, Left ventricular end-diastolic diameter and BNP than control group (P<0.05).
LVEF was signiﬁcantly higher in enhanced heart rate control group than in control
group (P<0.05).
Conclusions: The study shows that heart rate control with Metoprolol Succinate
Sustained-release Tablets can antagonize sympathetic activity as well and may
improve prognosis in patients with STEMI.
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Objectives: To study the distribution characteristics of TCM four diagnostic infor-
mation and syndrome of patients with Acute Coronary Syndrome (ACS).
Methods: The demographic data and TCM four diagnostic information of 300 eligible
patients were collected through the clinical epidemiologic methods, and then hier-
achical clustering methods and frequency analysis methods were adopted for data
analyzing by STATISTICA 6 software and SPSS17.0 statistical software.
Results: (1) Endogenous collateral wind was an independent syndrome of TCM chest
pain; (2) Qi deﬁciency was the main and facultative syndrome of endogenous
collateral wind; (3) Blood stasis syndrome had less correlation with endogenous
collateral wind than Qi deﬁciency; (4) Endogenous collateral wind syndrome also
related to Yin deﬁciency.
Conclusions: It is the preliminary evidence that endogenous collateral wind is the
important pathogenesis of acute coronary syndrome.
GW25-e0153
Outcomes in Patients with Non-ST-Elevation Acute Coronary Syndrome
Randomly Assigned to An Invasive as Compared with A Conservative Strategy:
A Meta-Analysis
Li Yingqing1, Liu Na2, Lu Jianhua1
1Guangzhou First People’s Hospital, Guangzhou Medical University, 2Sun Yat-sen
University Cancer Center
Objectives: The goal of the present study was to compare the prognosis of patients
with non-ST-elevation acute coronary syndromes (NSTE-ACS) which treated by
invasive or conservative treatment strategy.
Methods: We performed a meta-analysis of studies in patients with NSTE-ACS to
assess the beneﬁt between invasive and conservative strategy for short- and long-term
survival. We searched PubMed for published studies from 1990 to November 2012
that studied the effects of an invasive vs. conservative strategy in patients with NSTE-
ACS, and using the search terms non-ST-elevation myocardial infarction, unstableJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Cangina, acute coronary syndromes, invasive strategy and conservative strategy. The
primary endpoints were all-cause mortality at 30 days and 1 year.
Results: Seven published studies were included in the present meta-analysis. The
pooled analyses shows that invasive strategy decrease the chance of death (risk ratio
[RR] [0.839] [95% conﬁdence interval [CI] {0.648-1.086}; I2, 86.46%]) compared to
conservative strategy during 30 days. Furthermore, invasive treatment could also
decrease the mortality (RR [0.276] [95% CI {0.259-0.294}; I2, 94.58%]) compared to
conservative strategy until 1 year.
Conclusions: In NSTE-ACS, compared with conservative strategy, the invasive
strategy has a comparable beneﬁt to decrease the mortality of short- and long-term.
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JAK2V617F mutant positive polycythemia Vera complicating acute coronary
syndrome: a report of 2 cases and literature review
Yang Ming, Zeng Yong
Peking Union Medical College Hospital
Objectives: To review the clinical features, diagnosis, prognosis and treatment of
polycythemia Vera (PV) complicating acute coronary syndrome (ACS).
Methods: The clinical data of two PV complicating ACS patients admitted to Peking
Union Medical College Hospital were retrospectively analyzed and the review of
recent literatures was performed.
Results: Case 1 was a 65-year old man who had been diagnosed PV with a positive
result of JAK2V617F mutation 3 years ago. At presentation, the patient was suffering
from recurrent angina pecteris, and coronary angiography revealed that there was a
severe (80%) lesion in the middle segment of left circumﬂex and a Xience V stent was
implanted. After the percutaneous transluminal coronary intervention (PCI), second-
ary prevention for coronary heart disease and hydroxyurea for PV were given and the
patient has been followed up regularly for more than three years and he is going on
well. Case 2 is a 44-year old man who was diagnosed PV with a positive result of
JAK2 mutation 3 years ago and hydroxyurea, interferon, aspirin was prescribed. He
was then to develop splenic infarction, thrombosis of splenic vein,regional portal
hypertension, severe varices of fundus of stomach and upper gastrointestinal
bleeding. 2 months ago, an AMI of inferior wall occurred and the angiographic
ﬁndings demonstrated an thrombotic lesion in the proximal segment of the right
coronary artery with a moderate stenosis (60%). 1 month ago,an AMI of anterior wall
developed and coronary angiography discovered that there were diffuse thrombus in
the proximal segment of left anterior descending artery with a severe stenosis (90%)
and a complete occlusion in the right coronary artery. After double antiplatelet
therapy with anticoagulation therapy of warfarin was given, the patient recovered
gradually.
Conclusions: PV complicating ACS is relatively rare. According to recent studies,
positive result of JAK2V617F mutation, leukocytosis, age greater than 65 years and
positive history of thrombosis were the most important predictors of cardiovas-
cular events. Clinicians should combine clinical features, Coronary angiography
ﬁndings and complications in hope of making an individualized treatment. For
those with thrombotic lesion in the coronary artery due to the hypercoagulative
state caused by PV, it should be cautious to carry out a coronary revascularization
treatment.
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Objectives: Proinﬂammatory dendritic cells (DC) and monocytes are critically
involved in the proceeding and destabilization of atherosclerosis. Recent studies have
reported potential associations of speciﬁc patterns of circulating DCs and monocytes
with the incidence of coronary artery disease (CAD) and ST-elevation myocardial
infarction (STEMI); however, further information of DC and monocyte subsets on
plaque morphology and vulnerability is uncertain and required.
Methods: Forty-seven CAD patients with borderline lesions (stenosis 50%-70%) by
coronary angiography (CAG) were enrolled, while 31 subjects free of luminal
diameter narrowing  50% served as controls. Likewise, 35 patients with STEMI
were enrolled and conﬁrmed with the presence of thrombosis by CAG. Plaque features
of 47 CAD patients were evaluated at the site of the minimum lumen area and culprit
lesions by optical coherence tomography. Peripheral blood (6 ml) was collected from
each patient and drawn into heparin-anticoagulated tubes at entry. Circulating myeloid
DCs (mDCs), plasmacytoid DCs (pDCs) and monocyte subsets were analyzed using
ﬂow cytometry. Plasma levels of biomedical markers, including Lp-PLA2, PTX3,
FABP3, FABP4 and myeloperoxidase, were measured using commercial available
ELISA assays.
Results: There was no discrepancy in the peripheral total white blood cell count,
differential count among three groups. Compared to control group, patients with CAD
and STEMI had signiﬁcantly lower proportions of mDC1, mDC2, pDC and a
remarkable higher proportion of monocytes with intermediate CD16 expression
(Mon2, CD14+CD16+) in peripheral blood. In the OCT subgroup, patients with thin-
cap ﬁbroatheroma (TCFA) had a lower proportion of mDC2 than those without TCFA
(0.70%  0.38% and 1.42%  0.51%, P¼0.021). Otherwise, Mon2 proportion
retained a higher level in patients with TCFA relative to those without TCFA
(17.82%  3.69% and 14.19%  2.37%, P¼0.034). When proportions wereardiovascular Disease Clinical Research C125
